Questions raised by the benelux CML study group: Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia - Response

JC Kluin-Nelemans; A Delannoy; A Louwagie; Benelux CML Study Grp

Questions raised by the benelux CML study group: Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia - Response

JC Kluin-Nelemans^*, A Delannoy, A Louwagie, Benelux CML Study Grp

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	2986-2987
Number of pages	2
Journal	Blood
Volume	92
Issue number	8
Publication status	Published - 15-Oct-1998
Externally published	Yes

Keywords

CHRONIC MYELOGENOUS LEUKEMIA
REQUIRING PROLONGED OBSERVATION
PATIENT
DESIGN

Handle.net

Persistent link

Cite this

@article{dd9a371a045b4dd58ad719b521cb52da,

title = "Questions raised by the benelux CML study group: Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia - Response",

keywords = "CHRONIC MYELOGENOUS LEUKEMIA, REQUIRING PROLONGED OBSERVATION, PATIENT, DESIGN",

author = "JC Kluin-Nelemans and A Delannoy and A Louwagie and {Benelux CML Study Grp}",

year = "1998",

month = oct,

day = "15",

language = "English",

volume = "92",

pages = "2986--2987",

journal = "Blood",

issn = "0006-4971",

publisher = "AMER SOC HEMATOLOGY",

number = "8",

}

Questions raised by the benelux CML study group: Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia - Response. / Kluin-Nelemans, JC; Delannoy, A; Louwagie, A et al.
In: Blood, Vol. 92, No. 8, 15.10.1998, p. 2986-2987.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Questions raised by the benelux CML study group

T2 - Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia - Response

AU - Kluin-Nelemans, JC

AU - Delannoy, A

AU - Louwagie, A

AU - Benelux CML Study Grp

PY - 1998/10/15

Y1 - 1998/10/15

KW - CHRONIC MYELOGENOUS LEUKEMIA

KW - REQUIRING PROLONGED OBSERVATION

KW - PATIENT

KW - DESIGN

M3 - Letter

SN - 0006-4971

VL - 92

SP - 2986

EP - 2987

JO - Blood

JF - Blood

IS - 8

ER -